Vivesto AB (OTCPK:OASMY)
$ 0.0499 0 (0%) Market Cap: 8.95 Mil Enterprise Value: 3.84 Mil PE Ratio: 0 PB Ratio: 0.87 GF Score: 33/100

Q4 2020 Oasmia Pharmaceutical AB Earnings Call Transcript

Jun 18, 2020 / 06:00AM GMT
Release Date Price: $1.9
Operator

Welcome to the Oasmia Pharmaceutical Q4 2020. With us today, we have François Martelet, [CEO] of the Board. (Operator Instructions) I will now hand over to your speakers. Please go ahead.

FranÃ;ois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB

§ - ()-

Thank you very much, and welcome to everyone attending this call -- this quarterly report call that I will be pleased to go through right now.

So if you could move the presentation to Slide 3. So you will see that I will be doing this together with our CFO, Michael af Winklerfelt.

On Slide 4, you see that we will -- I will give you an overview of Oasmia. I will go through the quarterly events and forward results, and obviously, the key drivers from an outlook perspective, and then I will end this presentation before the Q&A with a summary of the presentation.

Now let's turn to Slide 5. So on this slide, that does show pretty well what we are, and I have to say that we are not a drug delivery company as one could think about. But we are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot